Most Read Articles
2 days ago
There appears to be a high rate of emergency department (ED) admission for acute exacerbation of chronic obstructive pulmonary disease (AECOPD), with patients having significant in-hospital mortality, according to data from the *AANZDEM study. Furthermore, compliance with evidence-based treatments in the ED is suboptimal.
Tristan Manalac, 6 days ago
Of the newly identified genetic loci for primary angle-closure glaucoma (PACG), two are significantly associated with primary angle-closure suspect (PACS), indicating involvement in the earlier stages of the disease, a recent Singapore study has shown.
Pearl Toh, 3 days ago
Patients with inflammatory bowel disease (IBD) who had primary nonresponse to an anti-tumour necrosis factor (TNF) agent ─ or inadequate response to the initial loading doses ─ were less likely to respond to second-line biologics compared with those who had secondary loss of response (LOR) or intolerance to the primary therapy, according to a systematic review and meta-analysis presented at the Crohn's & Colitis Congress (CCC) 2018 held recently in Las Vegas, Nevada, US.
Tristan Manalac, 16 Feb 2018
Placebo pills, even when administered open-label, appear to significantly improve cancer-related fatigue and fatigue-disrupted quality of life, according to a recent study.

Morning fasting upregulates insulin signalling in adipose tissue

06 Dec 2017
It is a commonly-held assumption that breakfast is the most important meal of the day, but it could inadvertently be doing the body harm.

Skipping breakfast may contribute to better insulin signalling, according to a recent study, which shows that expression of the IRS2 gene, involved in insulin signalling, is upregulated in both lean and obese individuals following a 6-week morning fasting programme.

The research team performed a randomized controlled trial on 29 healthy lean (mean age 36±11 years; 64 percent female) and 20 obese (mean age 43±10 years; 65 percent female) individuals, from whom subcutaneous abdominal tissue (SCAT) biopsies were collected at baseline and after 6 weeks of morning fasting or daily breakfast consumption.

In lean individuals, extended morning fasting resulted in significantly upregulated genes involved in lipid turnover (ACADM gene; p=0.007) and insulin signalling (IRS2 gene; p=0.03) pathways, as opposed to those who had regular breakfasts. There were no significant impacts on other genes, including those involved in inflammation and mitochondrial signalling.

In comparison, morning fasting did not significantly affect the expression of the ACADM gene in obese individuals (p>0.1). Only the expression of the IRS2 gene was significantly upregulated following the 6-week fasting programme (p=0.049). Other genes involved in insulin signalling, and which were proximal to IRS2 in the pathway, were likewise unaffected by fasting.

According to researchers, the present findings indicate that changes in adipose tissue glucose control, as a result of morning fasting, are most probably due to proteins involved in signalling.

“Finally, lower insulin-stimulated SCAT glucose uptake rates in obese individuals are proportional to whole-body fat mass, suggesting a compensatory downregulation, presumably to prevent excessive de novo lipogenesis in adipose tissue,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
2 days ago
There appears to be a high rate of emergency department (ED) admission for acute exacerbation of chronic obstructive pulmonary disease (AECOPD), with patients having significant in-hospital mortality, according to data from the *AANZDEM study. Furthermore, compliance with evidence-based treatments in the ED is suboptimal.
Tristan Manalac, 6 days ago
Of the newly identified genetic loci for primary angle-closure glaucoma (PACG), two are significantly associated with primary angle-closure suspect (PACS), indicating involvement in the earlier stages of the disease, a recent Singapore study has shown.
Pearl Toh, 3 days ago
Patients with inflammatory bowel disease (IBD) who had primary nonresponse to an anti-tumour necrosis factor (TNF) agent ─ or inadequate response to the initial loading doses ─ were less likely to respond to second-line biologics compared with those who had secondary loss of response (LOR) or intolerance to the primary therapy, according to a systematic review and meta-analysis presented at the Crohn's & Colitis Congress (CCC) 2018 held recently in Las Vegas, Nevada, US.
Tristan Manalac, 16 Feb 2018
Placebo pills, even when administered open-label, appear to significantly improve cancer-related fatigue and fatigue-disrupted quality of life, according to a recent study.